On Tuesday, Cathie Wood-led Ark Invest continued to purchase shares of Archer Aviation Inc (NASDAQ:ACHR), a flying taxi company. This move comes a day after Ark Invest’s significant purchase of Archer shares.

The Archer Aviation Trade: Ark Invest acquired a substantial number of shares of Archer Aviation for the second consecutive day. The trade, made through the ARK Innovation ETF (NYSE:ARKK), was valued at $16 million, based on Archer’s closing price of $5.94.

The firm’s interest in Archer has been evident, especially after the eVTOL aircraft maker recently secured a $215 million equity investment from industry giants like Boeing Co, Stellantis N.V., and United Airlines. This investment boosted Archer’s total funding to over $1.1 billion.

Furthermore, Archer’s Midnight eVTOL aircraft received FAA approval, and the company announced a collaboration with Boeing and Wisk Aero for autonomous flight technology. Adam Goldstein, CEO of Archer, expressed optimism about the U.S. government’s commitment to eVTOL aircraft and the collaboration with industry leaders.

See Also: Cathie Wood's Ark Invest Sees Hope For Greener Skies With AI-Driven Flight Paths

In addition to the Archer Aviation acquisition, Ark Invest also made a notable decision to sell shares of Shopify Inc (NYSE:SHOP). The Innovation ETF sold Shopify shares worth $10.08 million, based on the stock’s closing price of $55.34 on Wednesday.

Shopify’s stock has been on a rollercoaster ride, especially after the company’s second-quarter results. Despite reporting a 31% year-over-year increase in revenue and surpassing analyst estimates, Shopify shares experienced volatility. The company’s president, Harley Finkelstein, highlighted the firm’s strong financial results and emphasized their focus on expanding the global merchant base.

Other Key Trades:

• Recurson Pharmaceuticals (NASDAQ:RXRX) – Purchased 219,586 shares through ARK Genomic Revolution ETF (BATS:ARKG).
• Ginkgo Bioworks Holdings Inc (NASDAQ:DNA) – Purchased a combined total of 396,419 shares across ARKK and ARKG.
• Intellia Therapeutics Inc (NASDAQ:NTLA) – Purchased a combined total of 18,755 shares across ARKK and ARKG.
• Exact Sciences Corp (NASDAQ:EXAS) – Sold 78,164 shares through ARKK.

Read Next: Cathie Wood-Led Ark Investment Management Identifies Tesla’s Three Key Growth Catalysts